Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PSDV - pSivida Limited -- Ignore unavailable to you. Want to Upgrade?

To: kenhott who wrote (173)	9/25/2009 5:06:42 PM
From: John McCarthy	Respond to of 421

Did the company mention when they will PR the 180 (?) day look? They are pass due. ken not sure what the above means - but I am gonna answer anyway - and say - NO. as best I recall - the only talk about trials was the std yada_yada that the p3 trial results will be out in December .... regards John

To: kenhott who wrote (173)	9/25/2009 5:14:50 PM
From: Arthur Radley	Read Replies (1) \| Respond to of 421

Ken, The CEO said it would be by the end of the year, and that they hadn't taken a peek at the data, as of yet. However, the final patient's waiting period should be coming up soon, and then it will take at least a few weeks to review.....I'm thinking that we should expect something around the end of Nov. or early December. Much is riding on this for both PSDV and Alimera.....if the data is positive I think they want the NDA filed ASAP as the $500,000.00 monthly payment coming to PSDV starts ticking in early 2010. Alimera needs some money or at leAst the hope of getting some coming into the till and keeping their VCs happy. These guys(VS) want to cash in by taking Alimera public........good Phase III data will grease the wheels for the IPO. (IMO)